Evidence map›Paper›PMID 29854835›Full record

ArticleJournal of immunology research2018

March1 E3 Ubiquitin Ligase Modulates Features of Allergic Asthma in an Ovalbumin-Induced Mouse Model of Lung Inflammation.

Osama A Kishta, Antoine Sabourin, Leora Simon, Toby McGovern, Maxime Raymond, Tristan Galbas, Abdelilah Majdoubi, Satoshi Ishido, James G Martin, Jacques Thibodeau

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Curcumin Inhibits the Growth of Hepatocellular CarcinomaRecent patents on anti-cancer drug discovery · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Broad-Spectrum Profiling of Drug Safety via Learning Complex Network.Clinical pharmacology and therapeutics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Osama A KishtaUniversité de Montréal, Laboratoire d'immunologie moléculaire, Département de microbiologie, Infectiologie et Immunologie, Montreal, QC, Canada H3T 1J4.ORCID 0000-0003-2420-2726
Antoine SabourinUniversité de Montréal, Laboratoire d'immunologie moléculaire, Département de microbiologie, Infectiologie et Immunologie, Montreal, QC, Canada H3T 1J4.
Leora SimonMcGill University Health Center, Meakins-Christie Laboratories for Lung Research, Montreal, QC, Canada 4HA 3J1.
Toby McGovernMcGill University Health Center, Meakins-Christie Laboratories for Lung Research, Montreal, QC, Canada 4HA 3J1.ORCID 0000-0003-1721-3734
Maxime RaymondUniversité de Montréal, Laboratoire d'immunologie moléculaire, Département de microbiologie, Infectiologie et Immunologie, Montreal, QC, Canada H3T 1J4.
Tristan GalbasUniversité de Montréal, Laboratoire d'immunologie moléculaire, Département de microbiologie, Infectiologie et Immunologie, Montreal, QC, Canada H3T 1J4.
Abdelilah MajdoubiUniversité de Montréal, Laboratoire d'immunologie moléculaire, Département de microbiologie, Infectiologie et Immunologie, Montreal, QC, Canada H3T 1J4.
Satoshi IshidoDepartment of Microbiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan.
James G MartinMcGill University Health Center, Meakins-Christie Laboratories for Lung Research, Montreal, QC, Canada 4HA 3J1.
Jacques ThibodeauUniversité de Montréal, Laboratoire d'immunologie moléculaire, Département de microbiologie, Infectiologie et Immunologie, Montreal, QC, Canada H3T 1J4.ORCID 0000-0002-0790-9634
Université de Montréal · CAMcGill University Health Centre · CAHyogo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membrane-associated RING-CH-1 (March1) is a member of the March family of E3 ubiquitin ligases. March1 downregulates cell surface expression of MHC II and CD86 by targeting them to lysosomal degradation. Given the key roles of MHC class II and CD86 in T cell activation and to get further insights into the development of allergic inflammation, we asked whether March1 deficiency exacerbates or attenuates features of allergic asthma in mice. Herein, we used an acute model of allergy to compare the asthmatic phenotype of March1-deficient and -sufficient mice immunized with ovalbumin (OVA) and later challenged by intranasal instillation of OVA in the lungs. We found that eosinophilic inflammation in airways and lung tissue was similar between WT and March1

Indexed as

AllergensAnimalsAsthmaCytokinesDisease Models, AnimalHumansImmunoglobulin ELungLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutNeutrophil InfiltrationOvalbuminPneumoniaUbiquitin-Protein LigasesAllergensCytokinesImmunoglobulin EMARCH1 protein, mouseOvalbuminUbiquitin-Protein Ligases

Identifiers

PMID29854835
PMCPMC5960577
OpenAlexW2799837105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.